| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cabiralizumab | macrophage colony-stimulating factor 1 receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of pancreas[MeSHID:D010190] Pancreatic carcinoma[MeSHID:C562463] |
1.06 | phase 2 | antibody |
| cabiralizumab | macrophage colony-stimulating factor 1 receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of pancreas[MeSHID:D010190] Pancreatic carcinoma[MeSHID:C562463] |
1.06 | phase 2 | unknown |
| cabiralizumab | granulocyte-macrophage colony-stimulating factor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of pancreas[MeSHID:D010190] Pancreatic carcinoma[MeSHID:C562463] |
0.78 | phase 2 | unknown |
| click here to return to the previous page | ||||||||